Syndax Pharmaceuticals Historical PE Ratio image   This SNDX PE ratio history page last updated 3/12/2024
Syndax Pharmaceuticals Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/27/2024
24.41-1.00-4.00NA
Q3 2023
11/2/2023
14.78-0.73-2.92NA
Q2 2023
8/3/2023
20.35-0.64-2.56NA
Q1 2023
5/8/2023
20.29-0.59-2.36NA
Q4 2022
2/28/2023
25.35-0.62-2.48NA
Q3 2022
11/3/2022
22.33-0.58-2.32NA
Q2 2022
8/8/2022
24.28-0.62-2.48NA
Q1 2022
5/9/2022
15.11-0.63-2.52NA
Q4 2021
3/1/2022
16.061.817.242.2
Q3 2021
11/15/2021
17.89-0.40-1.60NA
Q2 2021
8/9/2021
14.55-0.44-1.76NA
Q1 2021
5/11/2021
16.04-0.54-2.16NA
Q4 2020
3/8/2021
23.30-0.44-1.76NA
Q3 2020
11/2/2020
17.09-0.46-1.84NA
Q2 2020
8/6/2020
15.00-0.42-1.68NA
Q1 2020
5/7/2020
18.01-0.56-2.24NA
Q4 2019
3/3/2020
9.27-0.44-1.76NA
Q3 2019
11/7/2019
6.96-0.41-1.64NA
Q2 2019
8/7/2019
9.51-0.47-1.88NA
Q1 2019
5/6/2019
7.36-0.53-2.12NA
Q4 2018
3/7/2019
6.27-0.70-2.80NA
Q3 2018
11/5/2018
4.86-0.68-2.72NA
Q2 2018
8/7/2018
6.65-0.74-2.96NA
Q1 2018
5/8/2018
10.32-0.79-3.16NA
Q4 2017
3/5/2018
9.96-0.80-3.20NA
Q3 2017
11/7/2017
10.70-0.68-2.72NA
Q2 2017
8/10/2017
11.15-0.70-2.80NA
Q1 2017
5/8/2017
7.99-0.71-2.84NA
Q4 2016
3/2/2017
12.02-0.59-2.36NA
Q3 2016
11/10/2016
10.25-0.84-3.36NA
Q2 2016
8/9/2016
14.20-0.47-1.88NA
Q1 2016
5/16/2016
12.89-2.85-11.40NA
Syndax Pharmaceuticals PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/27/2024
24.41-1.00-2.96NA
Q3 2023
11/2/2023
14.78-0.73-2.58NA
Q2 2023
8/3/2023
20.35-0.64-2.43NA
Q1 2023
5/8/2023
20.29-0.59-2.41NA
Q4 2022
2/28/2023
25.35-0.62-2.45NA
Q3 2022
11/3/2022
22.33-0.58-0.02NA
Q2 2022
8/8/2022
24.28-0.620.16151.7
Q1 2022
5/9/2022
15.11-0.630.3444.4
Q4 2021
3/1/2022
16.061.810.4337.3
Q3 2021
11/15/2021
17.89-0.40-1.82NA
Q2 2021
8/9/2021
14.55-0.44-1.88NA
Q1 2021
5/11/2021
16.04-0.54-1.86NA
Q4 2020
3/8/2021
23.30-0.44-1.88NA
Q3 2020
11/2/2020
17.09-0.46-1.88NA
Q2 2020
8/6/2020
15.00-0.42-1.83NA
Q1 2020
5/7/2020
18.01-0.56-1.88NA
Q4 2019
3/3/2020
9.27-0.44-1.85NA
Q3 2019
11/7/2019
6.96-0.41-2.11NA
Q2 2019
8/7/2019
9.51-0.47-2.38NA
Q1 2019
5/6/2019
7.36-0.53-2.65NA
Q4 2018
3/7/2019
6.27-0.70-2.91NA
Q3 2018
11/5/2018
4.86-0.68-3.01NA
Q2 2018
8/7/2018
6.65-0.74-3.01NA
Q1 2018
5/8/2018
10.32-0.79-2.97NA
Q4 2017
3/5/2018
9.96-0.80-2.89NA
Q3 2017
11/7/2017
10.70-0.68-2.68NA
Q2 2017
8/10/2017
11.15-0.70-2.84NA
Q1 2017
5/8/2017
7.99-0.71-2.61NA
Q4 2016
3/2/2017
12.02-0.59-4.75NA
Q3 2016
11/10/2016
10.25-0.84NANA
Q2 2016
8/9/2016
14.20-0.47NANA
Q1 2016
5/16/2016
12.89-2.85NANA
Quotes delayed 20 minutes

Email EnvelopeFree SNDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Syndax Pharmaceuticals (SNDX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SNGX PE Ratio History
SNOA PE Ratio History
SNPX PE Ratio History
SNSE PE Ratio History
SOLY PE Ratio History
SONN PE Ratio History
SONX PE Ratio History
SPNE PE Ratio History
SPPI PE Ratio History
SPRB PE Ratio History
How should the SNDX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Syndax Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SNDX Historical PE Ratio page.

What is the average historical PE for SNDX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SNDX historical PE ratio using the annualized quarterly earnings method works out to 2.2.

What is the average historical PE for SNDX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SNDX historical PE ratio using the TTM earnings method works out to 77.8.

On this page we presented the Syndax Pharmaceuticals Historical PE Ratio information for Syndax Pharmaceuticals' stock. The average SNDX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SNDX historical PE based on this TTM earnings result method is 77.8. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SNDX historical PE result, against the recent PE: when this page was posted on 3/11/2024, the most recent closing price for SNDX had been 23.57, and the most recent quarterly earnings result, annualized, was 7.24. Meanwhile, the most recent TTM earnings summed to 0.16. From these numbers, we calculate the recent SNDX PE on 3/11/2024 based on annualized quarterly EPS was 3.3. Based on SNDX's history, that recent PE is elevated relative to the historical average, with the recent PE 50.0% higher than the historical average PE across our data set for Syndax Pharmaceuticals. Looking at the recent SNDX PE on 3/11/2024 based on TTM EPS, we calculate the ratio at 147.3. Based on SNDX's history, that recent PE is elevated relative to the historical average, with the recent PE 89.3% higher than the historical average PE across our Syndax Pharmaceuticals data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on SNDX or any other given stock, valuation analysis for SNDX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Syndax Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SNDX. Thanks for visiting, and the next time you need to research SNDX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: BAH shares outstanding history, DNMR shares outstanding history, VCXA Historical Stock Prices.

 

Syndax Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.